ClinicalTrials.Veeva

Menu

Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy

M

Motus GI

Status

Completed

Conditions

CRC

Treatments

Device: Motus Gl CleanUp System

Study type

Observational

Funder types

Industry

Identifiers

NCT02161549
CP-MCU-SP-1211

Details and patient eligibility

About

Motus Gl is developing a single-use device that attaches to a standard colonoscope, thereby integrating colon cleansing, screening and treatment into one procedure.

The device creates turbulence within the colon using water jets. The colon's fecal fluids are evacuated by the system.

Full description

63 eligible subjects who are allocated for a diagnostic screening colonoscopy were enrolled in the study. The assignment of the level of the bowel preparation agent was according to the physician decision. Following preparation, enrolled subjects were intubated and cleansed using a standard colonoscope with the Motus GI CleanUp device attached to it. At the end of the procedure, subjects were followed through discharge and at 48 hours post procedure for occurrence of adverse events.

40 subjects were enrolled under protocol Rev 1.0 used Motus GI CleanUp System Rev 1.0 31 subjects were enrolled under protocol Rev 2 used Motus GI CleanUp System Rev 1.5, due to improvement made to the study device including the following:

  1. One head that irrigates and evacuates instead of two heads
  2. Elimination of the grinding mechanism and the motor to reduce the pipes' diameters while keeping the same flow rate.
  3. System adjustment to the above changes including updated software version.

Enrollment

71 patients

Sex

All

Ages

50 to 69 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects in the age range of 50-69 years
  • Subjects who are considered for routine screening colonoscopy
  • Subjects with BMI within the range of 18.5-30
  • Subject is willing to sign informed consent form

Exclusion criteria

  • History of G diseases or history of Colorectal cancer (personal or family)
  • Previous major abdominal surgeries
  • Medical status ASA grater or equal to 3
  • Acute Gl symptoms, such as bleeding, unexplained weight loss, inflammatory bowel disease (lBD).
  • Patients taking anticoagulants (e.g., Coumadin, Heparin, Clopidrogrel)
  • Life-threatening condition
  • Subjects who are unable or unwilling to cooperate with study procedures
  • Severe Diverticula

Trial design

71 participants in 2 patient groups

Colonoscopy with MotusGi CleanUp System Rev 1.0
Description:
subjects indicated for colonoscopy procedure with CleanUp System Rev 1.0 , enrolled under protocol Rev 1.0
Treatment:
Device: Motus Gl CleanUp System
Colonoscopy with MotusGi CleanUp System Rev 1.5
Description:
subjects indicated for colonoscopy procedure with CleanUp System Rev 1.5 , enrolled under protocol Rev 2.0
Treatment:
Device: Motus Gl CleanUp System

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems